NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

BaheA.00113.b: 3-oxoacyl-(acyl carrier protein) synthase II

Target Characteristics

from organism: Bartonella henselae str. Houston-1
most recent status: in PDB
center reference id: BaheA.00113.b
is community request: True
associated disease: Bacillary angiomatosis
NIH risk group: 3
is select agent: False
NIH priority
pathogens category:
I

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
BaheA.00113.b.A1.GE25178 Full length( BaheA.00113.b ) 1 420 GE25178
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
BaheA.00113.b.A1.PW25216 Full length( BaheA.00113.b ) 1 420

Structures

image of structure for 3E60
3E60
Deposited: 8/14/2008
Determination: XRay
Diffraction Image
Clone: BaheA.00113.b.A1.GE25178
Protein: BaheA.00113.b.A1.PW25216

External Resources

Resource Reference ID
OrthoMCL: OG5_126985
PATRIC ID: fig|283166.5.peg.586
RefSeq: YP_033372.1
UniProt: A0A0H3LW83

Enzyme & Pathway Information

Pathway Pathway ID EC Number
biotin biosynthesis I BIOTIN-BIOSYNTHESIS-PWY 2.3.1.179
fatty acid elongation -- saturated FASYN-ELONG-PWY 2.3.1.179
superpathway of fatty acid biosynthesis initiation (E. coli) FASYN-INITIAL-PWY 2.3.1.179
(5Z)-dodecenoate biosynthesis I PWY0-862 2.3.1.179
superpathway of fatty acid biosynthesis I (E. coli) PWY0-881 2.3.1.179
stearate biosynthesis III (fungi) PWY3O-355 2.3.1.179
superpathway of fatty acid biosynthesis II (plant) PWY-5156 2.3.1.179
petroselinate biosynthesis PWY-5367 2.3.1.179
palmitate biosynthesis II (bacteria and plants) PWY-5971 2.3.1.179
cis-vaccenate biosynthesis PWY-5973 2.3.1.179
superpathway of mycolate biosynthesis PWY-6113 2.3.1.179
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate) PWY-6282 2.3.1.179
superpathway of unsaturated fatty acids biosynthesis (E. coli) PWY-6284 2.3.1.179
superpathway of fatty acids biosynthesis (E. coli) PWY-6285 2.3.1.179
8-amino-7-oxononanoate biosynthesis I PWY-6519 2.3.1.179
octanoyl-[acyl-carrier protein] biosynthesis (mitochondria, yeast) PWY-7388 2.3.1.179
gondoate biosynthesis (anaerobic) PWY-7663 2.3.1.179
oleate biosynthesis IV (anaerobic) PWY-7664 2.3.1.179
(5Z)-dodecenoate biosynthesis II PWY-7858 2.3.1.179

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MRRVVITGLG LVSPLAGDVE YSWKRLLEGK SGVRRITEFD VSDLSCQIAA RIPVGDGTNG TYNADLHMES KEQRKVDAFI VYAIAAADQA LADAEWFPKS DEDQICTGVL IGSGIGGIEG IVEAGYTLRD KGPRRISPFF IPGRLINLAS GYVSIKYGLR GPNHSVVTAC STGAHAIGDA ARLIALGDAD VMLAGGTESP INRISLAGFS ACRALSTCRN DDPERASRPY DVDRDGFVMG EGAAIVVLEE LEHAKKRGAR IYAEIIGYGL SGDAYHITAP SESGEGAQRS MMAALKRAQV NVSELDYINA HGTSTMADVI ELAAVERVLG YYAPQVSMSS TKSSIGHLLG AAGAAEAIFC VLAIRDNIAP ATLNLENPSI ETKIDLVPHK PRERKIDTVL SNSFGFGGTN ASLVMRRFSE

NT Sequence
ATGAGGCGTG TTGTTATTAC TGGTTTAGGA TTGGTATCTC CATTAGCTGG TGATGTCGAG TATAGTTGGA AACGACTTCT TGAAGGAAAA AGTGGTGTTC GACGCATTAC TGAATTTGAT GTATCCGACT TATCGTGCCA GATTGCTGCG CGTATCCCCG TAGGGGATGG TACAAATGGT ACATATAATG CTGATTTGCA TATGGAATCC AAGGAGCAGC GTAAGGTTGA TGCATTTATT GTTTATGCAA TTGCAGCCGC TGACCAAGCA CTTGCAGATG CTGAGTGGTT TCCCAAGAGT GATGAAGACC AGATTTGCAC AGGTGTGTTA ATTGGTTCGG GTATTGGTGG CATTGAAGGG ATTGTTGAGG CTGGTTATAC GCTTCGTGAT AAAGGTCCAC GGCGTATTTC TCCTTTTTTT ATTCCAGGAC GTTTGATTAA TCTTGCTTCT GGTTATGTAT CTATTAAATA TGGTTTGCGT GGTCCTAATC ATTCGGTTGT AACGGCCTGT TCAACAGGTG CACATGCCAT TGGTGATGCA GCACGTTTGA TTGCGTTGGG TGATGCAGAT GTGATGCTAG CAGGTGGCAC TGAATCCCCG ATAAATCGAA TATCTCTTGC TGGTTTTTCT GCTTGTCGAG CTCTTTCTAC TTGTCGTAAT GATGATCCTG AACGGGCATC ACGTCCTTAT GATGTTGATC GTGATGGTTT TGTGATGGGG GAAGGAGCAG CGATTGTTGT TTTAGAAGAG CTTGAACATG CAAAAAAACG AGGTGCTCGT ATTTATGCTG AGATTATTGG CTATGGTCTA TCTGGTGACG CTTACCACAT TACAGCACCT TCAGAGAGTG GTGAAGGTGC GCAGCGTAGT ATGATGGCTG CTCTTAAGCG TGCACAAGTG AATGTAAGCG AACTTGATTA CATTAATGCT CACGGTACAT CGACGATGGC TGATGTTATA GAATTGGCTG CTGTTGAGCG TGTTTTGGGC TATTATGCAC CACAAGTATC CATGTCATCA ACAAAGTCAT CTATAGGACA TTTACTTGGT GCAGCTGGTG CAGCTGAGGC TATTTTTTGT GTTTTAGCTA TACGAGATAA TATAGCTCCA GCAACACTTA ATCTTGAAAA TCCATCAATT GAAACGAAAA TTGACCTTGT TCCACATAAA CCGCGCGAGC GAAAAATTGA TACAGTTCTA TCCAATTCTT TTGGATTTGG TGGAACAAAT GCGTCTTTAG TGATGCGGCG TTTTTCGGAA

© 2020 Seattle Children's Research Institute. All rights reserved.